Breast cancer: Poor short-term prognosis in cases with moderate lymphocyte infiltration at the tumour edge: A preliminary report

Oncology Reports

Volumn 5, Issue 2, 1998, Pages 423-426

  Hartveit, F ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Breast cancer; Lymphocyte infiltration; Prognosis

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031935533     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.2.423     Document Type: Article

References (16)

1. Hamlin IME: Possible host resistance in carcinoma of the breast A histological study. Br J Cancer 22: 383-401, 1968.
2. Underwood JCE: Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. Br J Cancer 30: 538-548, 1974.
3. Rilke F, Colnaghi MI, Cascinelli N, Andreola S, Baldini MT, Bufalino R, Della Porta G, Menard S, Pierotti MA and Testari A: Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other proanostic factors. Int J Cancer 49: 44-49, 1991.
4. Carlomango C, Perrone F, Lauria R, Laurentiis M, Gallo C, Morbabito A, Pettinato G, Panico L, Bellelli T, Apicella A, Petrella G, Bianco AR and Placido SD: Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer. Oncology 52: 272-277, 1995.
5. Hartveit F and Lilleng PK: Breast cancer: two metastatic variants in the axilla that differ in prognosis. Histopathology 28: 241-246, 1996.
6. Hartveit F: The routine histological investigation of axillary lymph nodes for metastatic breast cancer. J Pathol 143: 187-191, 1984.
7. Scarff RW and Torlini H: Histological typing of breast tumours. In: International Histological Classification of Tumours. Vol. II. WHO, Geneva, pp17-18, 1968.
8. Bloom HGJ, Richardson WW and Field JR: Host resistance and survival in carcinoma of the breast: A study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. BMJ 3: 181-188, 1970.
9. Aaltomaa S, Lipponen P, Eskelinen M, Kosma V-M, Marin S, Alhava E and Syrjanen K: Prognostic factors after 5 years follow-up in female breast cancer. Oncology 49: 93-98, 1992.
10. Rosen PP, Saigo PE, Braum DW, Weathers E and De Palo A: Predictors of recurrence in stage I (T1N0M0) breast carcinoma. Ann Surg 193: 16-25, 1981.
11. Bilik R, Mor C, Wolloch Y and Dintsman M: Histopathologic risk factors influencing the prognosis of patients with early breast cancer (T1N0M0). Am J Surg 151: 460-464, 1986.
12. Bilik R, Mor C, Hazaz B and Moroz C: Characterization of T-lymphocyte subpopulations infiltrating breast cancer. Cancer Immunol Immunother 28: 143-147, 1989.
13. Silverstein JM: Diagnosis and treatment of early breast cancer. BMJ 314: 1736-1739, 1997.
14. Rosen PP, Saigo PE, Braum DW, Weathers E and Kinne DW: Prognosis in stage II (T1N1M0) breast cancer. Ann Surg 194: 576-584, 1981.
15. Holmberg L, Adami H, Lindgren A, Ekbom A, Sandstrøm A and Bergstrøm R: Prognostic significance of the Ackerman classification and other histopatological characteristics in breast cancer. APMIS 96: 979-990, 1988.
16. Lee LHS, Happerfield LC, Millis R and Bobrow LG: Inflammatory exudate in invasive lobular and ductal carcinoma of the breast. Br J Cancer 74: 796-801, 1996.